These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23312965)

  • 21. [Osteoporosis associated with chronic obstructive pulmonary disease and other respiratory diseases].
    Balzarini L; Mancini C; Mouzakiti P; Confortini M; Marvisi M
    Recenti Prog Med; 2011 Sep; 102(9):359-66. PubMed ID: 21947192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory versus field walking tests in moderate COPD: value in simplicity?
    Georgiopoulou V
    Respirology; 2012 Feb; 17(2):197-8. PubMed ID: 22221901
    [No Abstract]   [Full Text] [Related]  

  • 23. [Early diagnosis of chronic obstructive pulmonary disease (COPD)].
    Gillissen A; Juergens UR; Menz G
    MMW Fortschr Med; 2005 Mar; 147(11):36-8, 40. PubMed ID: 15803848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of airway resistance measurements by the forced oscillation technique and the interrupter technique for detecting chronic obstructive pulmonary disease in elderly patients.
    Guo YF; Sun TY; Herrmann F; Janssens JP
    Chin Med J (Engl); 2005 Nov; 118(22):1921-4. PubMed ID: 16313849
    [No Abstract]   [Full Text] [Related]  

  • 25. Hospital admission rates among men and women with symptoms of chronic bronchitis and airflow limitation corresponding to the GOLD stages of chronic obstructive pulmonary disease--a population-based study.
    Ekberg-Aronsson M; Löfdahl K; Nilsson JA; Löfdahl CG; Nilsson PM
    Respir Med; 2008 Jan; 102(1):109-20. PubMed ID: 17928213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiologic evidence linking antioxidant vitamins to pulmonary function and airway obstruction.
    Schünemann HJ; Freudenheim JL; Grant BJ
    Epidemiol Rev; 2001; 23(2):248-67. PubMed ID: 12192736
    [No Abstract]   [Full Text] [Related]  

  • 27. Up in smoke: the fallacy of the harmless Hookah.
    Chan A; Murin S
    Chest; 2011 Apr; 139(4):737-738. PubMed ID: 21467052
    [No Abstract]   [Full Text] [Related]  

  • 28. Pulmonary dysfunction, smoking, socioeconomic status and the risk of developing rheumatoid arthritis.
    Bergström U; Jacobsson LT; Nilsson JÅ; Berglund G; Turesson C
    Rheumatology (Oxford); 2011 Nov; 50(11):2005-13. PubMed ID: 21859698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression.
    Brajer B; Batura-Gabryel H; Nowicka A; Kuznar-Kaminska B; Szczepanik A
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():145-52. PubMed ID: 19218638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What is chronic obstructive pulmonary disease anyway?: Continua, categories, cut points, and moving beyond spirometry.
    Rennard SI; Vestbo J; Agustí A
    Am J Respir Crit Care Med; 2013 May; 187(10):1036-7. PubMed ID: 23675708
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits.
    Lindberg A; Jonsson AC; Rönmark E; Lundgren R; Larsson LG; Lundbäck B
    Respiration; 2005; 72(5):471-9. PubMed ID: 16210885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [COPD guideline of Japanese Respiratory Society].
    Kitamura S
    Nihon Rinsho; 2003 Dec; 61(12):2077-81. PubMed ID: 14674313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nasal symptoms, airway obstruction and disease severity in chronic obstructive pulmonary disease.
    Hurst JR; Kuchai R; Michael P; Perera WR; Wilkinson TM; Wedzicha JA
    Clin Physiol Funct Imaging; 2006 Jul; 26(4):251-6. PubMed ID: 16836700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Airway cell patterns in patients suffering from COPD and OSAS (Overlap Syndrome).
    Lacedonia D; Salerno FG; Sabato R; Carpagnano GE; Aliani M; Palladino GP; Barbaro MP
    Respir Med; 2011 Feb; 105(2):303-9. PubMed ID: 21130635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural history of successive COPD exacerbations.
    Wedzicha JA; Donaldson GC
    Thorax; 2012 Nov; 67(11):935-6. PubMed ID: 22858927
    [No Abstract]   [Full Text] [Related]  

  • 36. Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey.
    Celli BR; Halbert RJ; Nordyke RJ; Schau B
    Am J Med; 2005 Dec; 118(12):1364-72. PubMed ID: 16378780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bibliography. Current world literature. Obstructive, occupational and environmental diseases.
    Curr Opin Pulm Med; 2002 Mar; 8(2):137-49. PubMed ID: 11883392
    [No Abstract]   [Full Text] [Related]  

  • 38. Gender and chronic obstructive pulmonary disease in high-risk smokers.
    de Torres JP; Campo A; Casanova C; Aguirre-Jaime A; Zulueta J
    Respiration; 2006; 73(3):306-10. PubMed ID: 16330871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chronic obstructive pulmonary disease (COPD): diagnosis and treatment].
    Kardos P
    Dtsch Med Wochenschr; 2004 Mar; 129(10):490-3. PubMed ID: 14986237
    [No Abstract]   [Full Text] [Related]  

  • 40. Smoking: relationship to chronic bronchitis, chronic obstructive pulmonary disease and mortality.
    Pelkonen M
    Curr Opin Pulm Med; 2008 Mar; 14(2):105-9. PubMed ID: 18303418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.